Mural Health
Samuel Whitaker is a seasoned entrepreneur and executive with extensive experience in the health technology sector. As Co-Founder and Co-CEO of Mural Health since January 2022, Samuel also serves as an Angel Investor with Project Mayhem Ventures and has founded ENDK. Previously, Samuel held the position of Chief Technology Officer at Signant Health and founded Greenphire, where leadership roles included CEO and Board Member. Earlier career highlights include Vice President of Product Management at Ecount and various roles in investment banking at HSBC Global Banking and Markets and Legg Mason. Samuel earned a Bachelor of Arts in Philosophy from the University of Pennsylvania.
Mural Health
1 followers
Mural Health is a clinical trials technology company that is dedicated to making it easy to be a participant in clinical trials. Mural Health’s technology platform, Mural Link, is a patient-first technology that is primarily designed to benefit the study participant but also improves site operations and drives critical strategic value to study sponsors.